期刊文献+

射血分数保留心衰患者NT-proBNP与房颤的相关性研究 被引量:2

Association between NT-proBNP and atrial fibrillation in heart failure patients with preserved ejection fraction
下载PDF
导出
摘要 目的 探讨射血分数保留心力衰竭(HFpEF)患者血清N末端B型利钠肽原(NT-proBNP)水平及其他因素与房颤(AF)的相关性。方法 回顾性分析2020年1~8月就诊于我院心血管内科的HFpEF患者419例,其中合并AF 107例,检测血清NT-proBNP水平,根据血清NT-proBNP中位数水平(351pg/ml)分为两组(Q1组≤351pg/ml,Q2组>351pg/ml)。采用Logistic回归分析NT-proBNP及其他因素与AF的关系。结果 (1)高NT-proBNP组(Q2组)AF发生率高;(2) Logistic回归分析显示:高NT-proBNP水平[(OR=1.082,95%CI1.044~1.121),P<0.05],左心房内径(LAD)增大[OR=1.201,95%CI(1.129~1.277),P<0.05],平均心率增快[OR=1.033,95%CI(1.015~1.051),P<0.05]增加合并AF的风险;使用钙通道阻滞剂[OR=0.336,95%CI(0.172~0.657),P<0.05]降低合并AF的风险;(3) NT-proBNP水平与发生AF风险的拟合曲线显示:随着NT-proBNP水平增高,发生AF风险增大;(4) ROC曲线显示:NT-proBNP预测HFpEF患者合并AF的截断值为421pg/ml,曲线下面积为0.862,敏感度为83.8%,特异性为74.5%。结论 在HFpEF患者中,NTproBNP、LAD、心率、使用钙通道阻滞剂与AF相关,NT-proBNP预测HFpEF合并AF具有较高临床价值。 Objective To analyse the association between NT-proBNP level and atrial fibrillation(AF) in heart failure patients with preserved ejection fraction(HFpEF). Methods Selected 419 patients with HFpEF in our hospital from Jan to Aug, 2020, including 107 patients with AF. Patients were divided into two groups according to median NT-proBNP level, patients with NT-proBNP≤351pg/ml were in Q1 group, patients with NT-proBNP>351pg/ml were in Q2 group. Analysed the relationship between NT-proBNP and AF by Logistic regression, drew the fitting curve and ROC curve. Results(1) The incidence of AF in high NT-proBNP group(Q2 group) was high.(2) Logistic regression analysis showed that higher NT-proBNP level [OR=1.082, 95%CI(1.044~1.121), P<0.05], larger left atrial diameter [OR=1.201, 95%CI(1.129~1.277), P<0.05] and faster average heart rate [OR=1.033, 95%CI(1.015~1.051), P<0.05]increased the risk of AF, the use of calcium channel blockers [OR=0.336, 95%CI(0.172~0.657), P<0.05] reduced the risk of AF.(3)The fitting curve between NT-proBNP level and the risk of AF showed that the risk of AF increased with the increase of NT-proBNP level.(4) ROC curve showed that the cut-off value of NT-proBNP for predicting AF in HFpEF patients was 421pg/ml, the area under the ROC curve was 0.862,the sensitivity was 83.8%, and the specificity was 74.5%. Conclusion In HFpEF patients, NT-proBNP, LAD, heart rate and the use of calcium channel blockers are associated with AF. NT-proBNP has great clinical value in predicting HFpEF with AF.
作者 费思杰 张强 刘方方 孙彩红 信彩凤 白璐 Fei Sijie;Zhang Qiang;Liu Fangfang(the Second Affiliated Hospital of Zhengzhou University,Zhengzhou 450014)
出处 《中国现代医药杂志》 2023年第1期13-18,共6页 Modern Medicine Journal of China
基金 2022年河南省医学科技攻关联合共建项目(编号:LHGJ20220443)。
关键词 房颤 心力衰竭 射血分数 NT-PROBNP Atrial fibrillation Heart failure Ejection fraction NT-proBNP
  • 相关文献

参考文献4

二级参考文献61

  • 1Zhou ZQ, Hu DY, Chen J, et al. An epidemiological survey of atrial fibrillation in China[ J ]. Zhonghua Nei Ke Za Zhi,2004,43 ( 7 ) :491-494.
  • 2Tang WH, Francis GS, Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure [ J ]. Circulation, 2007,116 ( 5 ) : e99-109.
  • 3Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management [J]. Can J Cardiol,2006,22( 1 ) :23-45.
  • 4Heart Failure Society Of A HFSA 2006 Comprehensive Heart Failure Practice Guideline[J]. J Card Fail,2006,12( 1 ) :e1-2.
  • 5de Lemos JA,McGuire DK,Drazner MH. B-type natriuretic peptide in cardiovascular disease [ J ]. Lancet,2003,362 (9380) : 316 -322.
  • 6Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure [ J ]. Am J Physiol, 1998,274(5 pt 2) :H1684-1689.
  • 7Yeo KT,Wu AH ,Apple FS,et al. Multicenter evaluation of the Roche NT- proBNP assay and comparison to the Biosite Triage BNP assay[J]. Clin Chim Acta,2003,338 ( 1-2 ) : 107-115.
  • 8Ng LL, Loke IW, Davies JE, et al. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides [ J ]. J Am Coll Cardiol,2005,45 ( 7 ) : 1043-1050.
  • 9Luchner A, Hengstenberg C, Lowel H, et al. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP[ J]. Hypertension,2005,46( 1 ) : 118- 123.
  • 10Kistorp C, Raymond I, Pedersen F, et al. N-terminal pro-brain natriuretie peptide,C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults [ J ]. JAMA, 2005,293 ( 13 ) : 1609- 1616.

共引文献43

同被引文献34

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部